Join to View Full Profile
5230 Centre AvePittsburgh, PA 15232
Phone+1 412-623-6720
Dr. McCall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Neal McCall, MD, is a radiation oncology specialist based in Pittsburgh, PA. He completed his residency in radiation oncology at Emory University School of Medicine in 2023 following his graduation from Sidney Kimmel Medical College at Thomas Jefferson University in 2018. Dr. McCall has contributed to several notable publications in journals such as the Journal of Neurosurgery, American Journal of Clinical Oncology, and JAMA Oncology, focusing on topics like radiation necrosis, treatment patterns in CNS lymphoma, and proton therapy in head and neck cancers.
Education & Training
Emory University School of MedicineResidency, Radiation Oncology, 2019 - 2023
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018
Certifications & Licensure
PA State Medical License 2023 - 2026
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.Neal S McCall, Annabel Lu, Benjamin D Hopkins, David Qian, Kimberly B Hoang
Journal of Neurosurgery. 2025-04-01 - 1 citationsImpact of Systemic and Radiation Therapy on Survival of Primary Central Nervous System Lymphoma.James Robert Janopaul-Naylor, Jimmy S Patel, Manali Rupji, Kimberly Bojanowski Hoang, Neal Sean McCall
Cancers. 2025-02-12 - Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer.Neal S McCall, Kristin A Higgins
International Journal of Radiation Oncology, Biology, Physics. 2024-10-01
Press Mentions
Impact of Radiation Dose to Immune Cells in Unresectable or Stage III NSCLC in the Durvalumab EraAugust 8th, 2022- Highlights of WCLC 2022August 8th, 2022
- Remaining Questions Surrounding the Use of Radiotherapy in SCLCAugust 8th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
